Last reviewed · How we verify
NCT05372055: MY-IPC
Malignant Pleural Effusions: Evaluating the psYchosocial Impact of Indwelling Pleural Catheters on Patients
trial testing Semi-structure interviews in Malignant Pleural Effusion in 18 participants. Completed in 8 May 2023.
8 May 2023
Quick facts
| Lead sponsor | Guy's and St Thomas' NHS Foundation Trust |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 18 |
| Start date | 9 May 2022 |
| Primary completion | 8 May 2023 |
| Estimated completion | 8 May 2023 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Semi-structure interviews
Conditions studied
- Malignant Pleural Effusion — all drugs for Malignant Pleural Effusion →
- Indwelling Pleural Catheter — all drugs for Indwelling Pleural Catheter →
Sponsor
Guy's and St Thomas' NHS Foundation Trust
Who can join
18 and older, any sex, with Malignant Pleural Effusion or Indwelling Pleural Catheter. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to better understand the impact that Indwelling Pleural Catheters have on patients with malignant pleural effusions from a psychosocial point of view.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Psychosocial impact of living with an indwelling pleural catheter in patients with malignant pleural effusions: a thematic analysis.
Zhang J, Liang J, Agoramoorthy L, Montalvo S, et al · · 2025 · cited 1× · PMID 40628689 · DOI 10.1136/bmjresp-2024-002993
Verify or expand the search:
- PubMed search for NCT05372055
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Semi-structure interviews
Trials testing the same drug.
- NCT03936842 — Evaluation of an Educational Intervention for Women With Breast Pain · NA · unknown
Other recruiting trials for Malignant Pleural Effusion
Currently open trials in the same condition.
- NCT06421610 — OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion. · Phase 1 · recruiting
- NCT05620329 — UNC Pleural Fluid Registry · recruiting
Other Guy's and St Thomas' NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07534917 — Comparing the Effects of Newer Pacemakers and Their Effects on the Heart and Valve Function in the Short-term. · not yet recruiting
- NCT07454135 — Mechanisms of Atrial Pathoelectrophysiology in HCM · not yet recruiting
- NCT07419945 — Older Kidney Patient Optimisation Pretransplant · NA · not yet recruiting
- NCT07309835 — Improving Genetic Medicine for Ethnic Minority Groups · not yet recruiting
- NCT07203872 — Inflammation-resolution Therapy in MINST of Periodontal Intrabony Defect: a Pilot Randomised Controlled Trial · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05372055 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guy's and St Thomas' NHS Foundation Trust
- Last refreshed: 9 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05372055.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing